Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 18 | 2026 | 2244 | 2.970 |
Why?
|
| Gangliosidosis, GM1 | 3 | 2026 | 26 | 1.290 |
Why?
|
| Brain | 7 | 2026 | 1605 | 1.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2026 | 164 | 1.100 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 628 | 1.100 |
Why?
|
| Brain Ischemia | 3 | 2025 | 418 | 1.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2026 | 32 | 0.950 |
Why?
|
| Stroke | 2 | 2023 | 1211 | 0.790 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2025 | 87 | 0.770 |
Why?
|
| ErbB Receptors | 2 | 2013 | 127 | 0.690 |
Why?
|
| Glioma | 2 | 2013 | 101 | 0.690 |
Why?
|
| Genetic Therapy | 7 | 2026 | 839 | 0.690 |
Why?
|
| Contrast Media | 4 | 2026 | 432 | 0.680 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 2293 | 0.640 |
Why?
|
| Intestines | 1 | 2021 | 181 | 0.610 |
Why?
|
| Intracranial Aneurysm | 2 | 2023 | 382 | 0.580 |
Why?
|
| Collagen | 1 | 2019 | 135 | 0.550 |
Why?
|
| Kyphosis | 1 | 2018 | 6 | 0.550 |
Why?
|
| Achondroplasia | 1 | 2018 | 2 | 0.550 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 5 | 0.540 |
Why?
|
| Tay-Sachs Disease | 3 | 2025 | 52 | 0.540 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 91 | 0.540 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 70 | 0.530 |
Why?
|
| Spine | 1 | 2018 | 54 | 0.530 |
Why?
|
| Blood Vessels | 1 | 2017 | 63 | 0.520 |
Why?
|
| Animals | 20 | 2026 | 21345 | 0.510 |
Why?
|
| Hydrogels | 1 | 2018 | 127 | 0.490 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2026 | 298 | 0.450 |
Why?
|
| Genetic Vectors | 6 | 2026 | 918 | 0.420 |
Why?
|
| Biomimetics | 1 | 2014 | 31 | 0.410 |
Why?
|
| Dogs | 4 | 2026 | 315 | 0.410 |
Why?
|
| Liposomes | 1 | 2014 | 116 | 0.400 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 71 | 0.400 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 78 | 0.400 |
Why?
|
| Neuroimaging | 2 | 2025 | 164 | 0.390 |
Why?
|
| Molecular Imaging | 1 | 2013 | 52 | 0.390 |
Why?
|
| Tomography, Optical Coherence | 3 | 2026 | 235 | 0.380 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 222 | 0.370 |
Why?
|
| Coordination Complexes | 1 | 2012 | 9 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2026 | 699 | 0.370 |
Why?
|
| Thalamus | 2 | 2025 | 77 | 0.370 |
Why?
|
| Cerebral Angiography | 3 | 2023 | 299 | 0.370 |
Why?
|
| Manganese Compounds | 1 | 2012 | 8 | 0.360 |
Why?
|
| Peroxidase | 1 | 2012 | 70 | 0.360 |
Why?
|
| Humans | 27 | 2026 | 65140 | 0.360 |
Why?
|
| Chlorides | 1 | 2012 | 33 | 0.350 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 278 | 0.350 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 318 | 0.340 |
Why?
|
| Reproducibility of Results | 4 | 2026 | 1698 | 0.320 |
Why?
|
| Male | 15 | 2026 | 31047 | 0.310 |
Why?
|
| Dependovirus | 6 | 2026 | 751 | 0.300 |
Why?
|
| Microcirculation | 2 | 2026 | 59 | 0.290 |
Why?
|
| Female | 14 | 2026 | 34018 | 0.290 |
Why?
|
| beta-Galactosidase | 2 | 2026 | 84 | 0.280 |
Why?
|
| Disease Progression | 2 | 2025 | 1220 | 0.270 |
Why?
|
| Child, Preschool | 4 | 2026 | 2061 | 0.260 |
Why?
|
| White Matter | 2 | 2025 | 126 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 2 | 2025 | 183 | 0.250 |
Why?
|
| Cerebrospinal Fluid | 1 | 2026 | 29 | 0.240 |
Why?
|
| Cattle | 2 | 2019 | 320 | 0.240 |
Why?
|
| Infant | 3 | 2025 | 1693 | 0.230 |
Why?
|
| Treatment Outcome | 4 | 2026 | 5792 | 0.230 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2025 | 1 | 0.230 |
Why?
|
| Phenylketonurias | 1 | 2025 | 2 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 18 | 0.230 |
Why?
|
| Gray Matter | 1 | 2025 | 38 | 0.230 |
Why?
|
| Phenylalanine | 1 | 2025 | 25 | 0.230 |
Why?
|
| Respiration | 2 | 2017 | 93 | 0.230 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 36 | 0.220 |
Why?
|
| Solubility | 2 | 2018 | 192 | 0.220 |
Why?
|
| Atrophy | 1 | 2025 | 87 | 0.220 |
Why?
|
| Mice | 8 | 2025 | 11119 | 0.210 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 14 | 0.210 |
Why?
|
| Rats | 3 | 2013 | 1994 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 624 | 0.210 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 30 | 0.210 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 62 | 0.200 |
Why?
|
| Retrospective Studies | 3 | 2026 | 6872 | 0.200 |
Why?
|
| Cerebral Arteries | 1 | 2024 | 41 | 0.200 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 204 | 0.200 |
Why?
|
| Mice, Inbred DBA | 2 | 2014 | 84 | 0.200 |
Why?
|
| Child | 4 | 2026 | 4607 | 0.200 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2023 | 14 | 0.190 |
Why?
|
| Oligodendroglia | 2 | 2025 | 38 | 0.190 |
Why?
|
| Myelin Sheath | 2 | 2025 | 38 | 0.190 |
Why?
|
| Models, Anatomic | 1 | 2023 | 62 | 0.190 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 69 | 0.190 |
Why?
|
| Rats, Nude | 2 | 2013 | 25 | 0.190 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 169 | 0.180 |
Why?
|
| Infarction | 1 | 2022 | 21 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 105 | 0.180 |
Why?
|
| Rabbits | 1 | 2022 | 338 | 0.180 |
Why?
|
| Mutation | 3 | 2018 | 2661 | 0.180 |
Why?
|
| Radial Artery | 1 | 2022 | 55 | 0.170 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1141 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 1290 | 0.170 |
Why?
|
| Thrombectomy | 1 | 2023 | 256 | 0.160 |
Why?
|
| Demography | 1 | 2021 | 178 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 214 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3485 | 0.160 |
Why?
|
| Oxygen | 1 | 2022 | 319 | 0.160 |
Why?
|
| Injections | 1 | 2020 | 84 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1565 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 94 | 0.160 |
Why?
|
| Adult | 3 | 2026 | 17358 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 276 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 213 | 0.150 |
Why?
|
| Implants, Experimental | 1 | 2019 | 5 | 0.150 |
Why?
|
| Motion | 3 | 2026 | 64 | 0.140 |
Why?
|
| Movement | 2 | 2017 | 163 | 0.140 |
Why?
|
| Stents | 1 | 2022 | 498 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2017 | 483 | 0.140 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 20 | 0.140 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 27 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 875 | 0.130 |
Why?
|
| Diffusion | 1 | 2017 | 82 | 0.130 |
Why?
|
| Luciferases | 1 | 2018 | 107 | 0.130 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 118 | 0.130 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 98 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 6297 | 0.130 |
Why?
|
| Chelating Agents | 2 | 2018 | 49 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2018 | 77 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 53 | 0.120 |
Why?
|
| Heart | 2 | 2017 | 297 | 0.120 |
Why?
|
| Photoacoustic Techniques | 1 | 2015 | 4 | 0.120 |
Why?
|
| Ferric Compounds | 1 | 2015 | 42 | 0.120 |
Why?
|
| Dextrans | 1 | 2015 | 45 | 0.120 |
Why?
|
| Survival Rate | 1 | 2018 | 844 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 765 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 687 | 0.110 |
Why?
|
| Young Adult | 1 | 2025 | 4809 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 99 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 20 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 139 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1222 | 0.100 |
Why?
|
| Gold | 1 | 2015 | 235 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 232 | 0.100 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2012 | 3 | 0.090 |
Why?
|
| Pentetic Acid | 1 | 2012 | 33 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2025 | 325 | 0.090 |
Why?
|
| Drug Stability | 1 | 2012 | 144 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2012 | 84 | 0.090 |
Why?
|
| Antioxidants | 1 | 2014 | 249 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 49 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 70 | 0.090 |
Why?
|
| Gadolinium | 1 | 2012 | 110 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 326 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2012 | 293 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2011 | 14 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 464 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 167 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 760 | 0.080 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 84 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 3762 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 240 | 0.080 |
Why?
|
| Aged | 1 | 2026 | 14965 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 856 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2015 | 544 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 194 | 0.070 |
Why?
|
| Middle Aged | 1 | 2026 | 18273 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 250 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 788 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2026 | 15 | 0.060 |
Why?
|
| G(M1) Ganglioside | 1 | 2026 | 12 | 0.060 |
Why?
|
| Hydrodynamics | 1 | 2026 | 43 | 0.060 |
Why?
|
| Aspartate Aminotransferases | 1 | 2026 | 35 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2026 | 46 | 0.060 |
Why?
|
| Algorithms | 2 | 2026 | 1050 | 0.060 |
Why?
|
| Red Nucleus | 1 | 2025 | 5 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2026 | 175 | 0.060 |
Why?
|
| Abdomen | 2 | 2017 | 94 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 20 | 0.060 |
Why?
|
| Collateral Circulation | 1 | 2025 | 28 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 28 | 0.060 |
Why?
|
| Amygdala | 1 | 2025 | 85 | 0.060 |
Why?
|
| Corpus Callosum | 1 | 2025 | 42 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 126 | 0.050 |
Why?
|
| Oxadiazoles | 1 | 2024 | 8 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2026 | 187 | 0.050 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 57 | 0.050 |
Why?
|
| Microscopy | 1 | 2024 | 99 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 46 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 28 | 0.050 |
Why?
|
| Simvastatin | 1 | 2022 | 26 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 39 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 208 | 0.040 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 136 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 140 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2022 | 82 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 123 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 410 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2026 | 2483 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 290 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 189 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 325 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 508 | 0.030 |
Why?
|
| Cuprizone | 1 | 2018 | 3 | 0.030 |
Why?
|
| Remyelination | 1 | 2018 | 3 | 0.030 |
Why?
|
| PPAR delta | 1 | 2018 | 10 | 0.030 |
Why?
|
| Quetiapine Fumarate | 1 | 2018 | 13 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 15 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 2157 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 8 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 34 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 196 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 933 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 235 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 73 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 303 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 72 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 190 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1192 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1630 | 0.020 |
Why?
|